Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label, pilot study designed to explore whether daratumumab may have a
clinically meaningful effect in patients with mild to moderate Alzheimer's disease.